NDC 58160-725 – Fluarix 2026/2027
Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated) 15 ug/.5mL; Influenza A Virus A/croatia/10136rv/2023 X-425a (h3n2)… · Suspension · Intramuscular
Product NDC58160-725
Product details
- Brand name
- Fluarix 2026/2027
- Generic name
- Influenza virus vaccine
- Labeler
- GlaxoSmithKline Biologicals SA
- Dosage form
- Suspension
- Route
- Intramuscular
- Marketing category
- BLA · BLA125127
- Marketed since
- July 1, 2026
- Marketing end
- June 30, 2027
Active ingredients
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 58160-725-52 | 10 SYRINGE in 1 CARTON (58160-725-52) / .5 mL in 1 SYRINGE (58160-725-41) | Jul 1, 2026 |